To realize the benefits of globalization, companies must implement new strategies that capitalize on the benefits of globalization
and outsourcing while reducing and controlling risks. This article has outlined key challenges to managing global life-sciences
product supply chain and proposed approaches for maintaining better visibility and control over those product life cycles.
Simply put, it requires the use of information that is readily available, managed correctly, and shared to help to ensure
the safety, efficacy, and quality of products for all parties involved.
David J. Lennard is vice-president, and Daniel R. Matlis is founder and president, both of Axendia, firstname.lastname@example.org
To read Matlis' report on outsourcing's effect on process analytical technology and quality by design, see "Has Outsourcing Derailed PAT and QbD?"
1. Axendia, "Achieving Global Supply Chain Visibility, Control & Collaboration in Life Sciences: Business Imperative, Regulatory
2. US IPEC, "Joint Strategic Plan on Intellectual Property Enforcement" (Washington, DC, June 2010).